Identifying, financing and accompanying the future leaders of tomorrow
€690m
Under mgmt
150
exits and 26 IPO
Our successes
Life Sciences
- Microbiome / Nutrition / Foodtech / Lifestyle
- Connected Health & Food / Wellness
- Biotech & Pharmaceuticals
- Medtech & Diagnosis
- Industrial Biotech
Digital Technologies
- Fintech
- Saas Software Editor
- Innovative Services
- Infrastructure Technologies
News
-
5 November 2018Next decade set to herald industry confidence in microbiome-based therapies, says new report
Read more...Taking on board learnings from challenges already faced...
-
26 October 2018
Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development
Read more...Proceeds to fund Phase 2/3 trial of inhaled TD139 in...
-
25 October 2018
Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund
Read more...The company, which was founded in 2016 to develop...
-
23 October 2018
Enterome signs global licensing, co-development and co-promotion agreement with Takeda for the treatment of Crohn’s disease
Read more...Enterome, a clinical-stage biotech company developing...
-
16 October 2018
LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University
Read more...LNC aims to develop the first Christensenella-based drug...
Events
-
25 September
France Digitale Day, Paris
Come & meet us !
-
04 October
Fintech Tour – 4 October 2018 – MARSEILLE
Come & meet us ! http://bit.ly/2Ck2iBo
-
29 January
Microbiome Drug Development Summit – Paris, 29-31 January
Come & meet us !